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We document the impact of the AIDS crisis on non-AIDS related health services in fourteen sub-Saharan
African countries. Using multiple waves of Demographic and Health Surveys (DHS) for each country,
we examine antenatal care, birth deliveries, and rates of immunization for children born between 1988
and 2005. We find deterioration in nearly all of these dimensions of health care over this period. The
most recent DHS survey for each country collected data on HIV prevalence, which allows us to examine
the association between HIV burden and health care. We find that erosion of health services is highly
correlated with increases in AIDS prevalence. Regions of countries that have light AIDS burdens have
witnessed small or no declines in health care, using the measures noted above, while those regions
currently shouldering the heaviest burdens have seen the largest erosion in treatment for pregnant women
and children. Using semi-parametric techniques, we can date the beginning of the divergence in health















1.  Introduction 
In the past twenty years, the AIDS crisis has had crippling effects on the health care systems of 
many countries in sub-Saharan Africa. On the supply side, the pandemic may have compromised 
the ability of health systems to deliver care, as health professionals fell ill, or chose to leave for 
less-risky work elsewhere. The increase in morbidity that accompanies HIV may also have 
changed the nature of care offered by clinics and hospitals, reinforced by health budgets that 
shifted resources toward AIDS and the vertical delivery of care for those infected with HIV 
(Lancet 1995, Jones et al. 2003, Colvin 2005, Easterly 2008).  A recent World Bank evaluation 
(2009) also reports changes in its funding for health, nutrition and population programs (HNP) 
over the decade from 1997 to 2007, noting that “while the overall levels of lending in HNP have 
not changed much over the past decade, the composition of the portfolio has shifted rather 
dramatically toward communicable disease projects, particularly AIDS…” (page 23).  
AIDS may also have affected the demand for health services, by placing a large tax on 
households’ budgets. Prime-aged adults who fall ill may need to leave the labor force. Other 
family members may also find it necessary to change their work patterns, in order to care for the 
sick. These costs, together with the financial costs of covering illnesses associated with AIDS, 
can lead to ‘medical poverty traps’ (McIntyre et al. 2006).  
These strains on health systems and households have taken their toll. In this paper, we 
document the impact of the AIDS crisis on non-AIDS related health services in fourteen sub-
Saharan African countries. Using multiple waves of Demographic and Health Surveys (DHS) for 
each country, we examine antenatal care, birth deliveries, and rates of immunization for children 
born between 1988 and 2005. We find deterioration in the delivery of nearly all of these 
dimensions of health care over this period. The most recent DHS survey for each country collected data on HIV prevalence, which allows us to examine the association between HIV 
burden and health care. We find that erosion of health services is highly correlated with increases 
in AIDS prevalence. Regions of countries that have light AIDS burdens have witnessed small or 
no declines in health care, using the measures noted above, while those regions currently 
shouldering the heaviest burdens have seen the largest erosion in treatment for pregnant women 
and children. Using semi-parametric techniques, we can date the beginning of the divergence in 
health services between high and low HIV regions to the mid-1990s. 
We begin in Section 2 by introducing the DHS data we use to examine the impact of HIV 
on health care delivery. We discuss our estimation strategy in Section 3. We present evidence on 
the associations between HIV and health services in Section 4, and explore explanations for our 
findings in Section 5. Section 6 discusses ways in which future health service delivery may be 
affected by the arrival of antiretroviral therapy (ART), and notes that the design of AIDS care 
should take into account the fact that persons living in regions most affected by AIDS may not 
have been receiving adequate medical care for the past 20 years.  
 
2.  Demographic and Health Survey Data 
Demographic and Health Surveys are large, nationally representative household-based surveys 
conducted at approximately four to five year intervals in low and middle income countries. Their 
focus is primarily on population, health and nutrition. Women in the household aged 15 to 49 are 
asked about their fertility histories, including information on prenatal care, delivery assistance 
and children’s immunizations. In some survey waves, information on antenatal care is available 
for a woman’s most recent birth, and in others it is collected for all births that occurred within a 
particular time window (within the past three years for some surveys, within the past five years for others). Appendix Table 1 provides a guide to survey years. Information on these surveys is 
also available on line at http://www.measuredhs.com/aboutdhs/.  
  We analyze data from 41 DHS surveys conducted between 1988 and 2006 in fourteen 
countries in sub-Saharan Africa. We have data from eight West African countries where HIV 
prevalence rates are relatively low – Burkina Faso, Cameroon, Cote d’Ivoire, Ghana, Guinea, 
Mali, Niger and Senegal – and six countries in East and Southern Africa where rates are higher – 
Ethiopia, Kenya, Malawi, Tanzania, Zambia, and Zimbabwe.
1
Table 1 reports on the DHS data we use, including survey years, the birth years of 
children covered in each survey year, and the number of observations in each survey.
 (The exception to this geographic 
generalization is Ethiopia, where prevalence rates are much like those observed for Burkina Faso 
and Ghana.) We selected these countries because they have conducted multiple DHS surveys 
since 1988, and because their latest round of DHS data collection included HIV testing. We do 
not use the 1988 survey from Ghana and the 1991-92 survey from Tanzania, because the geo-
coding of within-country regions changed between these and later surveys.  
2
Our analysis will focus on the association between health service delivery on one hand, 
and HIV prevalence rates on the other. For this, we match HIV prevalence at the region level. 
All countries are divided into regions that can be consistently identified across survey years. 
 For each 
birth year from 1988 to 2005, we have observations from at least seven countries we are 
studying. For 1988 and 1989, 7 and 8 countries are represented. In all years beyond that, 
information is available from at least 9 countries for each birth year.    
                                                 
1All results presented here are robust to the exclusion of Zimbabwe, which may have seen more upheaval and 
displacement of persons than other countries examined.  
2 We exclude 133 cases where information on mother’s education is missing and 3509 cases where information on 
the HIV prevalence in the region of birth is unknown for the child’s birth year.  Countries vary in the number of regions (3 in Cameroon and in Malawi for example, 10 in 
Zimbabwe, 20 in Tanzania), and in total we analyze data from 119 regions.      
 
Antenatal Care 
Outcome measures for antenatal care are presented in Table 2. We present averages for each 
country, taken over all DHS waves, on women’s reports that they received any antenatal care (in 
the form of at least one antenatal visit). For women who report antenatal care, each is asked 
whether their urine and blood was tested, and whether measurements of their blood pressure and 
weight were taken.  With the exception of Ethiopia, over 90 percent of women surveyed in East 
and Southern Africa report some form of antenatal care, true for a smaller fraction of women in 
West Africa. In most countries in our sample, more than 90 percent of women report that they 
were weighed, conditional on reporting prenatal care, and the vast majority report their blood 
pressure was taken. Blood tests and urine analysis are much less likely to be reported in some 
countries (Ethiopia, Malawi, Mali, Niger, Zambia) than in others (Cameroon, Ghana, 
Zimbabwe).  
Figure 1 shows a marked decline in the tests and measurements taken during antenatal 
visits in East and Southern Africa, by country and birth year, particularly for tests involving 
bodily fluids. Results for urine and blood tests during antenatal care, shown in the upper panel of 
Figure 1, suggest that use of these tests declined in all high HIV-prevalence countries we are 
following (Kenya, KE; Malawi, MW; Tanzania, TZ; Zambia, ZM; and Zimbabwe, ZW). In 
Malawi, for example, the percentage of women reporting that their blood was tested as part of 
their prenatal care declined from 54 percent in 1995, to 20 percent in 2005. Reports that blood 
pressure was taken during an antenatal visit held constant in West Africa (estimated but not reported in Figure 1), but fell in East and Southern Africa, as can be seen in the bottom left panel 
of Figure 1. In Kenya, for example, reports of blood pressure being taken fell from 88 percent in 
1998 to 80 percent in 2003, and in Tanzania from 75 percent in 2000 to 64 percent in 2005. Even 
reports of being weighed, an inexpensive measure that takes little clinic time, declined over this 
period (although from a very high base – note that the graphing scales used are different for 
different procedures.)  We do not know how declines in these services have translated in to 
declines in health outcomes for women and their children—for example, it may be that the 
measurement of weight during pregnancy has little effect on birth outcomes. However, declines 
in blood testing during pregnancy may be a particular problem, if a lack of blood tests prevents 




Outcome measures for birth deliveries are presented in Table 3. In almost all countries under 
study, approximately half of all births are attended by a trained professional. Approximately a 
third of all births occurred in public clinics, and ten percent in private clinics. (The largest outlier 
here is Ethiopia, where reports of clinic births and having a trained professional at the birth are 
substantially lower.) 
That these patterns have been changing over time in high prevalence countries can be 
seen in Figure 2, which presents delivery details, by country and year, for the five high 
prevalence countries we follow in East and Southern Africa. The top left graph presents trends in 
whether the birth occurred in a clinic (public or private) and the top right on whether it was 
attended by a trained professional.  All of these countries saw a decline in the presence of a trained professional at the delivery. In Zambia, this declined from 51 to 37 percent between 1988 
and 2002. In Malawi, the attendance of a trained professional fell from 72 percent to 59 percent 
between 1988 and 2005. Private clinic delivery in high HIV-prevalence countries held fairly 
steady over this period, while reports of delivery in public clinics declined.  
 
Childhood immunizations 
The rates of childhood immunization against polio, measles, BCG, and DPT are reported by 
country in Table 4. DHS evidence on vaccinations is categorized as: no vaccine; mother reports 
vaccine (no card); vaccine recorded on card (no date); and vaccine is dated on card. There are 
many ways to categorize these reports. Our interest is in children missing vaccines, and for this 
reason we code variables equal to ‘1’ if the child is reported – either by the mother or on the 
health card – not to be vaccinated , and equal to ‘0’ if the mother reports the vaccine, or evidence 
of the vaccine is recorded on the child’s health card. Table 4 shows that approximately half of all 
children were reported not to have had a polio vaccine shortly after birth, but that this lack of 
vaccination falls to between 10 to and 30 percent of children at older ages in most countries. 
Between a 30 and 50 percent of all children are not vaccinated against measles, and between 10 
and 20 percent have not received BCG vaccines. Non-vaccination rates are generally higher in 
West African countries.  
 
HIV prevalence  
The HIV prevalence rates we use in our analysis were calculated using HIV test results from the 
most recent DHS surveys listed in Table 1. We use this information to calculate prevalence rates 
at the country-region level. Differences in prevalence between countries, and between regions within countries, can be seen in Figure 3, where weighted averages of HIV prevalence are 
presented by region for eight of the countries in our sample. HIV prevalence varies a great deal 
both across countries, and across regions within countries. The lowest prevalence rates are in 
Niger, Senegal and Mali, with values in all regions under 2.1 percent. There is substantial 
regional variation in HIV rates in the higher-HIV countries of Kenya, Malawi, Tanzania, and 
Zambia. In Zimbabwe, rates are uniformly high (12 percent or more). We turn, in Section 3, to 
the methods we will use to examine whether health services for pregnant women and children 
deteriorated in regions in which HIV prevalence grew most quickly.   
 
3. Methods 
Our key concern is whether higher HIV prevalence within regions is associated with lower 
quality health care for mothers and their children. As noted above, we do not observe HIV 
prevalence over multiple years, but only in the year in which the most recent survey was 
conducted. We follow two general strategies for estimating the relationship between prevalence 
and health care. Our first strategy is to regress each health care measure on imputed HIV 
prevalence in the region in the child’s year of birth, and on other control variables, including 
indicators for year of birth and country-region fixed effects. We impute HIV prevalence by 
assuming that regional HIV prevalence has increased linearly from a value of 0 in 1980 to the 
value observed in the most recent survey.
3
                                                 
3 Although it is difficult to date the beginning of the AIDS crisis in Africa, there is evidence of a “marked increase in 
cases in Africa during the late 1970’s and early 1980’s” (Quinn et al. 1986). The countries we study reported their 
first cases of AIDS in the early- to mid-1980’s. Below, we discuss how our results change if we use a later date, of 
1985 rather than 1980, to impute regional HIV prevalence. 
  Our second strategy is to regress each health care 
measure on a set of interactions between the child’s year of birth and the measure of HIV 
prevalence in the most recent survey. This permits us to examine whether the evolution of health outcomes from the late 1980s to the early 21
st century is different in regions with high HIV 
prevalence rates when compared to regions with low prevalence rates. As we show below, the 
second of these strategies is simply a less restrictive variant of the first: it does not require an 
assumption about the start of the epidemic, nor does it rely on the assumption that HIV 
prevalence increased linearly. 
  The first step is to impute HIV prevalence in each year in which children’s births are 
observed. Let 𝐻𝐻𝑟𝑟𝑟𝑟 denote the prevalence of HIV measured in region 𝑟𝑟 in year 𝑟𝑟, where 𝑟𝑟 is the 
most recent survey year (which exceeds 1980) and 𝑟𝑟 denotes a country-region. The estimated 
prevalence of HIV in region 𝑟𝑟 in year 𝑡𝑡, denoted ℎ𝑟𝑟𝑡𝑡, is assumed to be: 
(1)     ℎ𝑟𝑟𝑡𝑡 = 𝐻𝐻𝑟𝑟𝑟𝑟 �
𝑡𝑡−1980
𝑟𝑟−1980�. 
We then estimate regressions of the following form for each of the health outcomes discussed 
above: 
(2)     𝑦𝑦𝑖𝑖𝑟𝑟𝑡𝑡 = 𝗿𝗿𝑟𝑟 + 𝗾𝗾𝑡𝑡 + 𝗽𝗽ℎ𝑟𝑟𝑡𝑡 + 𝑋𝑋𝑖𝑖𝑟𝑟𝑡𝑡𝜃𝜃 + 𝜀𝜀𝑖𝑖𝑟𝑟𝑡𝑡, 
where 𝑦𝑦𝑖𝑖𝑟𝑟𝑡𝑡 is a health care measure associated with child 𝑖𝑖, either a measure of the quality of the 
care the child’s mother received before or at the birth of the child, or a measure of the quality of 
care the child has received. In addition to the prevalence measure, equation (2) contains a set of 
region fixed effects (𝗿𝗿𝑟𝑟), which capture time invariant features of the region, including 
determinants of quality of care that do not change over time. As seen in Figures 1 and 2, there 
are pronounced differences in the levels of the measures we examine, even though many have 
similar trends. We also include a set of birth year effects (𝗾𝗾𝑡𝑡), which capture changes over time 
that are common to all regions, and a set of controls for characteristics of the mother and child 
(𝑋𝑋𝑖𝑖𝑟𝑟𝑡𝑡). These controls include the mother’s years of education, her age in years, the child’s age in 
months (or, if the child has died, the age in months the child would have been at the time of the survey had he or she lived), an indicator for the child’s sex, and an indicator for whether the 
household lives in an urban area. The parameter of interest, 𝗽𝗽, provides an estimate of how 
changes in HIV prevalence in a region influence health care outcomes.
4
In what follows, we present estimates of (2) and (3). It is straightforward to see that (3) is 
a less restrictive version of (2). First, substitute (1) into (2) to obtain: 
𝑦𝑦𝑖𝑖𝑟𝑟𝑡𝑡 = �𝗿𝗿𝑟𝑟 − 𝗽𝗽
𝐻𝐻𝑟𝑟𝑟𝑟1980
𝑟𝑟 − 1980
� + 𝗾𝗾𝑡𝑡 + �
𝗽𝗽
𝑟𝑟 − 1980
�𝐻𝐻𝑟𝑟𝑟𝑟𝑡𝑡 + 𝑋𝑋𝑖𝑖𝑟𝑟𝑡𝑡𝜃𝜃  + 𝜀𝜀𝑖𝑖𝑟𝑟𝑡𝑡 
which, if: 
𝗿𝗿𝑟𝑟









can be expressed as: 
(4)     𝑦𝑦𝑖𝑖𝑟𝑟𝑡𝑡 = 𝗿𝗿𝑟𝑟
∗ + 𝗾𝗾𝑡𝑡
∗ + 𝗽𝗽∗𝐻𝐻𝑟𝑟𝑟𝑟𝑡𝑡 + 𝗼𝗼∗𝑋𝑋𝑖𝑖𝑟𝑟𝑡𝑡 + 𝜀𝜀𝑖𝑖𝑟𝑟𝑡𝑡. 
 
  Equation (2) incorporates two assumptions: one, that HIV prevalence increased linearly 
from 1980 to the current time period, and two, that HIV prevalence has a linear effect on health 
care quality. These assumptions can be loosened, by estimating models of the following form: 
(3)   𝑦𝑦𝑖𝑖𝑟𝑟𝑡𝑡 = 𝗿𝗿𝑟𝑟
∗ + 𝗾𝗾𝑡𝑡
∗ + 𝗽𝗽𝑡𝑡
∗𝐻𝐻𝑟𝑟𝑟𝑟 + 𝗼𝗼∗𝑋𝑋𝑖𝑖𝑟𝑟𝑡𝑡 + 𝜀𝜀𝑖𝑖𝑟𝑟𝑡𝑡, 
where all variables are defined as above, only the actual prevalence in year 𝑟𝑟 has replaced 
estimated prevalence in year 𝑡𝑡, and the coefficient on actual prevalence is permitted to vary by 
year. Because the prevalence measure does not vary over time within regions, and region fixed 
effects are included, the value of 𝗽𝗽𝑡𝑡
∗ must be set to zero for one of the years. 
                                                 
4 All results reported in Tables 5, 6 and 7 are robust to additionally allowing unobservables to be clustered at the 
region level.  In (4), the inclusion of an interaction term between the prevalence in year 𝑟𝑟 and the year of birth 
permits a linear trend in the outcome (over and above the year effects  𝗾𝗾𝑡𝑡
∗ ) that varies with HIV 
prevalence. The only difference between (4) and (3) is that, in (3), different time patterns in areas 
with high and low HIV prevalence are not restricted to a linear trend.  In the results that follow, 
we test whether this linear restriction can be rejected.  
  To see how estimates of equation (3) should be interpreted, consider predicted values of 
the outcome at two time periods, 1 and 2. Ignoring the control variables 𝑋𝑋𝑖𝑖𝑟𝑟𝑡𝑡, the difference in 
the predicted value of the outcome in region 𝑟𝑟 will be: 
(5)     𝑦𝑦 �𝑟𝑟2 − 𝑦𝑦 �𝑟𝑟1 = (𝗾𝗾 �2
∗ − 𝗾𝗾 �1
∗) + (𝗽𝗽 ̂
2
∗ − 𝗽𝗽 ̂
1
∗)𝐻𝐻𝑟𝑟𝑟𝑟. 
The year-to-year change in the outcome contains a component that is common to all regions, and 
another component that is scaled by the region’s HIV prevalence in year τ. 
  One concern is that not all outcomes are observed in all countries in all years of birth. For 
example, the indicator that a child did not receive a polio vaccine at birth is available only in 
Niger in 1988.  By a birth year of 1993, information on this vaccine is available for four 
countries, and by 1995 it is available for 13 countries. To prevent the birth year effects from 
reflecting the experience of only a few countries, we “trim” the sample for each outcome, so that 
regressions exclude birth years that do not have observations from at least four countries.  As a 
result of this trimming, estimates of models for specific antenatal care procedures cover the 
1995-2005 period; and polio at birth covers the 1993 to 2005 period. All other estimates cover 
the 1988-2005 period.  
 
 
 4. Results 
Table 5 presents estimates of equation (2), which measure the association between estimated 
HIV prevalence in the year of birth and antenatal care. We present the coefficient on HIV 
prevalence from OLS regressions for whether a woman reports having had prenatal care (column 
1) and, conditional on reporting care, that she reports having had a urine test, a blood test, blood 
pressure measured, and her weight measured (columns 2 to 5). The first row presents estimates 
from equation (2) where, in addition to estimated HIV prevalence, the only other controls are 
birth year indicators. The second row presents estimates from regressions that also include 
country-region fixed effects, and mother and child characteristics.
5 HIV prevalence is also 
associated with fewer Women in regions with high HIV prevalence are significantly more likely 
to report prenatal care. Relative to living in a region with zero prevalence, women living in a 
region with 10 percent HIV prevalence are 26 percentage points more likely to report antenatal 
care (top panel, column 1). However, when we include country-region fixed effects, so that 
identification comes from change in HIV prevalence within a region over time, we find that 
higher HIV prevalence is associated with a significantly lower probability of reporting antenatal 
care. This suggests that, on average, higher prevalence areas started from higher levels of 
prenatal care, and that HIV has taken a greater toll on service delivery there than in regions with 
low levels of HIV prevalence.
6
Increases in HIV prevalence are also associated with declines in the the types of 
procedures conducted during antenatal care. Conditional on reporting antenatal care, women in 
  
                                                 
5 Estimates using probit models yield similar results. 
6 Our result on reporting any antenatal care is also robust to the inclusion of country-by-year fixed effects.  
 regions with higher HIV prevalence are observed with lower probabilities of having urine tests, 
and of reporting that their blood pressure was taken. Controlling for country-region fixed effects 
magnifies these differences, so that all four of the measures of quality of prenatal care are 
significantly lower over time within a region as HIV prevalence rises. For example, within a 
region where HIV prevalence increased by 10 percentage points between 1995 and 2005, a 
woman is 21 percentage points less likely on average to report that her blood pressure was taken 
during prenatal care if she was pregnant in 2005, relative a woman who was pregnant in 1995. 
Because antenatal care is itself negatively associated with HIV prevalence (controlling for 
country-region fixed effects), these effects are magnified when we estimate models that do not 
condition on the receipt of antenatal care. For example, as shown in Table 5, the coefficient on 
HIV prevalence for having had a urine test is –2.22 when we restrict the sample to those who 
reported antenatal care. It falls to  –5.96 when we use the full sample of all births.  
Table 6 presents results on the association between estimated HIV prevalence in the year 
of birth and the quality of birth deliveries. Specifically, we estimate the association of HIV 
prevalence with an indicator that the birth occurred in a clinic (column 1) and, conditional on a 
clinic delivery, whether the clinic was public (column 2). In addition, we estimate the association 
between HIV prevalence and a trained attendant being present at the birth (column 3). Again, the 
results are markedly different with and without country-region fixed effects. In the absence of 
fixed effects (row 1), we find delivery at a clinic is significantly more likely in regions with high 
HIV prevalence. However, over time within a region (row 2), we find clinic delivery is 
significantly less likely to be reported as HIV prevalence increases. Without fixed effects, 
conditional on being a clinic birth, delivery is are significantly less likely to be at a public clinic. 
This coefficient, while still negative and significant, falls by two-thirds when country-region fixed effects are included. A disturbing finding in Table 6 is that, within regions over time, those 
with higher HIV prevalence see a significant drop in the probability that a trained birth attendant 
was present for the delivery. On average, a region that experienced a 10 percentage point 
increase in the rate of HIV prevalence witnessed a 14 percentage point drop in the probability of 
a trained attendant at the birth. Part of this drop is due to the lower probability that the delivery 
took place in a clinic (column 1), and part of this drop is due to the lower probability of an 
attendant, even conditioning on clinic delivery (column 4).  
Table 7 turns to children’s health care outcomes, and presents estimates of the association 
between HIV prevalence and children not reported to have had a polio vaccine soon after birth 
(column 1), or to have ever been immunized against polio, measles, BCG and DPT (columns 2 to 
5). With the exception of the polio vaccine at birth, high estimated HIV prevalence in the year of 
birth is significantly associated with ever having been immunized – remembering that a negative 
number is associated with higher vaccination rates (row 1). However, within regions over time, 
children in regions of high HIV prevalence are significantly less likely to be vaccinated against 
any of these diseases. Relative to children born in a particular region with zero HIV prevalence 
in 1988, those born in the same region in 2005 would be almost 30 percentage points less likely 
to be immunized against polio,  measles and DPT, and 20 percentage points less likely to be 
immunized against BCG if the prevalence rate had risen to 10 percent in 2005.
7
                                                 
7 Our results on vaccines are robust to additionally including country-by-year fixed effects.  
 This lack of 
immunization is occurring in areas in which individuals are quite vulnerable – in Kenya, for 
example, news has been released of the first reported case of polio in the past 20 years 
(Associated Press, February 25, 2009).  In summary, it appears that regions that are bearing the heaviest HIV burdens have 
become less able to care for pregnant women, provide trained attendants for birth deliveries, and 
immunize children.  
These results are built on the assumptions that HIV prevalence has increased linearly 
over time since 1980, and that prevalence has a linear relationship with our health care measures 
of interest. To check the robustness of our results to the assumption that the epidemic started in 
1980, we repeat the analyses described above, but assumed that HIV prevalence increased 
linearly from 1985 rather than 1980. In models with country-region fixed effects, this change has 
the effect of reducing the coefficients (in absolute value) so that HIV prevalence has a smaller 
association with each of the health outcomes. However, the reductions are not large. For 
example, the coefficient on prevalence in the regression for antenatal care declines in absolute 
value from –1.73 (as shown in Table 5) to –1.42.  The coefficient on prevalence in the regression 
for “no polio vaccine at birth” falls from 7.02 (as shown in Table 7) to 5.56. All coefficients 
remain statistically significant. 
Next, we completely relax these assumptions of linearity, by estimating models of the 
form of equation (3), reproduced here for convenience: 
 (3)   𝑦𝑦𝑖𝑖𝑟𝑟𝑡𝑡 = 𝗿𝗿𝑟𝑟
∗ + 𝗾𝗾𝑡𝑡
∗ + 𝗽𝗽𝑡𝑡
∗𝐻𝐻𝑟𝑟𝑟𝑟 + 𝗼𝗼∗𝑋𝑋𝑖𝑖𝑟𝑟𝑡𝑡 + 𝜀𝜀𝑖𝑖𝑟𝑟𝑡𝑡. 
Our estimates are shown graphically. Specifically, after estimating equation (3) for each 
health outcome, we predict what the value of the outcome would be in each birth year, for four 
HIV prevalence rates (𝐻𝐻𝑟𝑟𝑟𝑟 equal to 0, 5, 10 and 20 percent.) For these predictions, the region 
fixed effects 𝗿𝗿𝑟𝑟
∗ are averaged across all regions, and values of 𝑋𝑋𝑖𝑖𝑟𝑟𝑡𝑡 are replaced by their grand 
sample means. We then graph the predicted values of the outcomes over time, at the four 
prevalence levels. To interpret these graphs, it is important to note that we have set 1997 to be the omitted birth-year category for both 𝗾𝗾𝑡𝑡
∗ and 𝗽𝗽𝑡𝑡
∗, so that predicted values are equal, by 








+ 𝗼𝗼 �∗𝑋𝑋 � 
Although this normalization vertically “centers” the graphed lines around realistic values of the 
outcomes, it should be kept in mind that this normalization is arbitrary. Indeed, as shown in 
Tables 2 through 4, average values of the health care outcomes differ widely across countries. 
Our interest is not particularly in the levels of predicted values, but rather how predicted values 
change over time, and how these changes vary with 𝐻𝐻𝑟𝑟𝑟𝑟. It is also important to keep in mind that, 
in the discussion of these estimates, “HIV prevalence” refers to 𝐻𝐻𝑟𝑟𝑟𝑟, the actual prevalence in a 
region, measured using data from the most recent DHS survey. 
  Figure 4 shows results for the indicator of whether the mother received antenatal care. 
Consistent with the estimates of equation (2), the figure indicates that in low prevalence regions, 
the use of antenatal care increased over time—by approximately 20 percentage points from 1988 
to 2005. However, this upward trend is less pronounced for higher prevalence rates. At 20 
percent prevalence, antenatal care is relatively constant from 1988 to 1995, and then declines by 
approximately 5 percentage points. Test statistics from the regression underlying Figure 4 are 
shown in the first row of Table 8. These indicate that the hypothesis that the birth year effects 𝗾𝗾𝑡𝑡
∗ 
are jointly insignificant can be rejected, as can the hypothesis that the birth year/HIV prevalence 
interactions 𝗽𝗽𝑡𝑡
∗ are jointly insignificant.  
The last column in Table 8 shows the results of tests of the hypothesis that the birth 
year/HIV prevalence interactions follow a linear trend—or, in other words, that the parameter 
restrictions imposed in equation (4) are valid. This hypothesis is rejected. This is not surprising, given that the changes in antenatal care at different prevalence rates shown in Figure 4 do not 
begin to diverge until the late-1990’s. The rejection of the hypothesis of a linear trend could be 
due to two factors. First, it could be that the evolution of HIV prevalence was non-linear. 
Second, it could be that the adverse effects of HIV on antenatal care have increased since the 
mid-1990’s. Without data on HIV prevalence over time, we cannot distinguish between these 
two factors.   
Results for the procedures women receive during antenatal care are shown in Figure 5. 
Consistent with the results in Table 5, differences in all of these procedures are apparent across 
high and low HIV prevalence regions, with the largest differences observed for urine tests and 
blood pressure. The use of blood tests is predicted to decline for all HIV prevalence rates shown, 
although more so for high HIV regions. The linearity restrictions are also rejected for these 
measures of care.  
Results for delivery care, in Figure 6, indicate that the largest differences across higher 
and lower HIV prevalence regions occur for the presence of a trained birth attendant. At 20 
percent prevalence, the presence of a trained birth attendant declines almost continuously, by 
more than 15 percentage points from 1988 to 2005. At zero prevalence, the presence of a trained 
birth attendant declines from 1988 to 1993, before leveling off and then increasing after 1999. 
Consistent with the results in Table 6, there are smaller differences across high and low 
prevalence regions for the indicators for whether the mother delivered in a clinic, whether clinic 
deliveries occurred in a public clinic, and whether trained attendants were present for clinic 
deliveries. 
Results for children’s vaccines are presented in Figures 7 and 8. In high HIV regions, 
mothers were increasingly likely to report that their child had not received a polio vaccine shortly after birth. For example, at 10 percent prevalence, the fraction of mothers who report no 
vaccine is estimated to have increased by 20 percentage points from 1993 to 2005.  In contrast, 
low HIV prevalence regions made gains in vaccinating children against polio shortly after birth. 
The figures for the other vaccines are noisier, but show the same general pattern. 
Overall, the estimates of the less restrictive models, using equation (3), are consistent 
with those reported in Tables 5 to 7: regions with high HIV prevalence rates experienced greater 
deterioration in antenatal care, and larger declines in the use of trained birth attendants and 
vaccinations, relative to low HIV regions. Estimates of the less restrictive models also allow us 
to date when health care quality began to diverge across higher and lower HIV regions. For both 
the use of antenatal care and for children’s vaccines, this divergence began in the mid-1990s. 
This timing is also consistent with reports issued about deterioration in health care delivery in 
sub-Saharan Africa in the mid-1990s, summarized by the Lancet (1995).  
 
5. Discussion 
There are several possible, non-competing explanations for the deterioration of non-HIV related 
health services observed in high prevalence regions. AIDS may have affected access to care.  
AIDS may also have reduced the demand for non-HIV related health services through its effect 
on households’ incomes. Alternatively, AIDS may have had little effect on demand for care, or 
access to care, but have had a large effect on the quality of care available. We discuss these in 
turn.  
 
Access to care  AIDS-related illnesses may have crowded out access to medical care between 1995 and 2005. 
This would have been prior to the arrival of antiretroviral therapy in nearly all regions, and it is 
possible that the high morbidity rates among those infected with HIV took an ever larger toll on 
access to care. High HIV burdens may have reduced funding for non-HIV-related medical care, 
producing closures of clinics or reductions in the range of services offered. Alternatively, high 
HIV burdens could put upward pressure on user fees charged for non-HIV related services.  
  The DHS surveys provide some information on the problems women experienced with 
access to services. Specifically, in the most recent surveys for all countries we examine (with the 
exception of Kenya), mothers are asked about problems they face accessing medical care. 
Specifically, they are asked which of the following items were “a big problem with access to 
medical care”: (1) not knowing where to go for care; (2) the distance required to get to care; (3) 
the lack of money to pay for medical care; and (4) the lack of transportation to get to a facility. If 
HIV burdens were responsible for forcing women to travel farther, or spend more to attend 
clinics, we would expect to see a difference in responses among women in West Africa, where 
HIV rates are low, and those in East and Southern Africa, where rates are high.  
Tabulations of responses to these questions are in Table 9. For each outcome, we find a 
uniform pattern across countries. Approximately 10 to 20 percent of women report not knowing 
where to go for medical care; 40 percent report that distance is a problem; 60 percent say money 
is an issue; and 40 percent say transportation is a problem. However, there is no divide between 
high and low HIV countries. We also ran regressions of each of these variables on HIV 
prevalence in the region, and a set of country indicators, and found no evidence that mothers 
living in high-prevalence regions within countries reported worse access to care. This result—that access to care measures are similar across low- and high-HIV countries 
and regions within countries—provides suggestive but not conclusive evidence that HIV has not 
altered access to care. It is possible that high-HIV countries (or regions within countries) had 
better access to care prior to the HIV crisis, and that they have experienced more rapid 
deteriorations in these measures of access.  Indeed, our results on health care use presented 
earlier indicate that, without controlling for region fixed effects, health care measures often look 
better in high-HIV regions. However, once country-region fixed effects are included—so we are 
essentially looking at changes over time within regions—we see a negative association between 
HIV prevalence and health care. The same could be true for access to care. As more rounds of 
DHS data are collected, it will be possible to examine within-region changes in access measures.  
     
Demand for health services    
Households in high-HIV regions may have become poorer, because of lost income due to illness, 
increases in funeral expenses, or greater demands on household resources that result from having 
to care for orphans. Lower wealth could, in turn, be responsible for the deterioration in health 
care in high-HIV regions. If so, we would expect that the estimated associations between 
regional prevalence and health care will become smaller, in absolute value, when we control for 
household wealth. 
The DHS surveys do not contain measures of financial wealth. However, they do collect 
information on household assets – ownership of bicycles, refrigerators, and radios, for example. 
We construct a measure of household assets equal to the sum of indicators for the ownership of a 
radio, television, refrigerator, bicycle, motorcycle and car.  We first examine whether asset 
ownership declined with HIV prevalence within regions. To test whether the HIV-prevalence effect might be working through household resources, we re-ran equation (2), including a control 
for the number of assets. We also estimated variants that included indicators for ownership of 
each of the six assets separately.  
Our results do not support the hypothesis that declines in wealth (as measured by assets) 
in high-HIV regions account for the deterioration in the quality of health care. It is not the case 
that the asset index declined significantly over time in high-HIV regions. Using a sample of 
mothers (rather than births), we regressed the asset index on a set of survey year indicators, 
country-region indicators, mother’s age and education, an indicator for urban status, and 
estimated HIV prevalence in the survey year. The coefficient on HIV prevalence was positive 
(0.919) rather than negative, although not significantly different from zero. The samples are 
somewhat smaller than those used previously, since some waves of data did not contain 
comparable asset information. However, in all cases, the addition of asset information has only 
small effects on the coefficient on HIV prevalence. 
Our results might be explained by HIV positive mothers being less likely to seek 
antenatal and other medical care, either because they are ill, or because they are poorer due to 
illness, or because clinics do not welcome them. We can explore this, using the last round of 
DHS data for each of the countries in our sample, because in those datasets we know whether 
mothers are HIV positive. We estimated regressions as in equation (2) for antenatal care, birth 
deliveries and children’s immunizations, which included a set of country-region fixed effects and 
an indicator for whether the woman was HIV positive. We find that HIV positive mothers are 1.5 
percentage points more likely to report having had antenatal care, with or without a control for 
the estimated regional HIV prevalence in the child’s birth year. Similarly, with or without 
controls for regional prevalence, HIV positive mothers are also significantly more likely to report having had urine and blood tested, and blood pressure taken.  They are 3.5 percentage points 
more likely to report a clinic delivery, and 3 percentage points more likely to report the presence 
of a trained professional at the delivery. Children of HIV positive mothers are no more or less 
likely than other children to have been immunized against polio, measles, BCG and DPT.  We 
take this as evidence against lower demand for health care by HIV positive mothers.  If anything, 
the results suggest that HIV positive women are more likely than others to seek medical care 
during pregnancy, or are given higher priority and better service in clinics. 
 
Quality of health services 
Our parametric and semi-parametric results suggest that the quality of services available plays a 
large role in the decline in care we observe in our data. Women who attend antenatal care clinics 
are receiving significantly fewer diagnostic tests during their visits – even tests as inexpensive as 
having weight taken. Those who report delivering children in clinics are significantly less likely 
to have a trained attendant at the delivery.   
These declines in quality could be due to a reduction in the supply of trained personnel as 
a consequence of the pandemic, or to a redirection of funds for supplies and trained medical 
professionals to care for HIV patients. The latter interpretation is consistent with findings of a 
qualitative-quantitative study conducted in Malawi and Ethiopia among health workers and 
NGOs, which found the introduction of support from the Global Fund to Fight AIDS, Malaria 
and Tuberculosis has led “to an increasing focus on the three focal diseases, rather than increased 
attention to broader health systems strengthening. As a result, existing health system challenges 
have been overlooked in many cases, and to some extent, other health priorities have been 
overshadowed” (Schott, Stillman and Bennett 2005, page 39). Grépin (2009) examines whether the influx of foreign aid earmarked to HIV/AIDS 
exacerbated a diversion of resources away from non-AIDS health care. Using data from 1990 to 
2006, she finds a negative association between country’s receipt of foreign aid for HIV/AIDS 
and measures of the quality of care. However, it is unlikely that the expansion of AIDS-targeted 
foreign aid explains a large part of what we see in our data. Grépin’s numbers indicate that 
foreign aid for AIDS grew little until the year 2000, and then escalated rapidly as funds for ART 
became available through PEPFAR and other programs. This pattern is consistent with increases 
in access to ART. The number of people in Sub-Saharan Africa receiving ART is estimated to 
have been only 100,000 in 2003, but then rose to 1.375 million in 2006, and 2.12 million in 2007 
(World Health Organization, 2008).  Our results indicate that the divergence in the quality of 
care between high- and low-AIDS regions began in the early- to mid-1990’s, before foreign aid 
for AIDS was significant, and when very few Africans were receiving ART. The expansion of 
ART is so recent that the data needed to examine its effects on health services are not yet 
available.  
 
6. Conclusions   
The next round of DHS data sets will be in the field after the arrival of ART in many 
regions of Africa. When these data sets become available, it may be possible to assess whether 
ART improves the quality of care received by pregnant women and children– either directly, 
through provision of resources for medical care more broadly – or indirectly, through a reduction 
in morbidity among HIV positive patients, or whether it crowds out non-AIDS-related medical 
care. Unfortunately, women and children in sub-Saharan Africa cannot wait for another round of DHS surveys to come on line. We must find alternative ways to investigate the roots of this 
erosion in services.  
  In the interim, care providers should take into account the fact that medical care in high 
prevalence regions has not been adequate since the mid-1990s, which may affect the diseases 
children face (measles, polio, DPT) and the quality of the care their mothers receive during 
pregnancy and delivery. References 
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BF4,CM4, ET4, ET3, GH4, 
GN4, KE4, ML5, ML4, 
MW4, MW3, NI5,  SN4, 
TZ4, TZ2, ZM4, ZW5, ZW4 
BF3,BF2, CI5, CI4, CM2, GH3, GN3, KE2, 
MW2, NI2, SN2, SN1, TZ1, ZM3, ZM2 
CI3, CM3, GH2, 




CM4, BF4, ET4, ET3, GH4, 
GN4,  KE4, ML5,  ML4, 
MW4, MW3, NI5,  SN4, 
TZ4, ZM4, ZW5, ZW4 




  BF4(alive only), B3(alive only), CI4 (alive 
only), CM4 (alive only),  ET4(alive only),  
ET3 (alive only),  GH4(alive only), GH3 
(alive only),  GN4 (alive only), GN3(alive 
only), KE4 (alive only),  ML5 (alive only),  
ML4 (alive only), MW4(alive only), MW3 
(alive only),  NI5 (alive only),  NI2 (all), 
SN4 (alive only), TZ4 (alive only), TZ2 
(alive only), TZ1 (alive only), ZM4 (alive 
only),  
CM3 (alive only), 
KE3(alive only), 
ML3 (alive only), 





  BF4(alive only), B3(alive only), BF2(all), 
CI4 (alive only), CM4(alive only), 
CM2(all),   ET4(alive only),  ET3 (alive 
only),  GH4 (alive only), GH3(alive only), 
GN4 (alive only),  GN3(alive only), 
KE4(alive only), KE2(all), KE1(alive only), 
ML5 (alive only), ML4 (alive only), MW4 
(alive only), MW3 (alive only), MW2 (all), 
NI5 (alive only),  NI2 (all),   SN4 (alive 
only),  SN1 (all),  SN (alive only), TZ4 
(alive only), TZ2 (alive only), TZ1 (alive 
only),  ZM4 (alive only), ZM3 (alive only), 
ZM2 (all), ZW5 (alive only), ZW4 (alive 
only),  ZW2(alive only)  
CI3 (alive only),  
CM3 (alive only), 
GH2(all), 
KE3(alive only), 
ML3 (alive only), 
NI3 (alive only),  
ZW3 (alive only)  
Trained birth 
attendant 
  BF4, BF3, BF2, CI5, CI4, CM4, CM2, ET4, 
ET3,  GH4, GH3, GN4,  GN3, KE4, KE2, 
KE1, ML5, ML4, MW4,  MW3, MW2, 
NI5, NI2,   SN4, SN2, SN1, SN, TZ4, TZ2, 
TZ1, ZM4, ZM3, ZM2, ZW5, ZW4, ZW2,  
CI3,  CM3, GH2, 
KE3, ML3, NI3, 





  BF4, BF3, BF2, CI5, CI4, CM4, CM2, ET4, 
ET3, GH4, GH3, GN4, GN3,  KE4, KE2, 
KE1, ML5, ML4, MW4, MW3, MW2, NI5,  
NI2,  SN4, SN2, SN1, TZ4, TZ2, TZ1, 
ZM4, ZM3, ZM2, ZW5, ZW4, ZW2,  
CI3, CM3, GH2, 
KE3, ML3, NI3,  
ZW3 
Notes: BF=Burkina Faso, CM=Cameroon, CI=Cote d’Ivoire, ET=Ethiopia, GH=Ghana, GN=Guinea, 
KE=Kenya, MW=Malawi, ML=Mali, NI=Niger, SE=Senegal, TZ=Tanzania, ZM=Zambia, 
ZW=Zimbabwe. Numbers are each country code refer to the survey wave, as defined by DHS.  
Figure 1. Prenatal care in high prevalence countries:  urine tests, blood tests, blood pressure 


































































































Figure 2. Birth deliveries in high prevalence countries: delivery in a clinic, attended by a trained 
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Figure 3. Regional HIV prevalence rates for selected countries  
Notes: Burkina Faso (BF); Cameroon (CM); Ghana (GH); Kenya (KE); Malawi (MW); Tanzania 




































BF CM GH KE MW TZ ZM ZW 















































































































































































1994 1996 1998 2000 2002 2004 2006
year of birth 











































































































































































1988 1992 1996 2000 2004
year of birth 
 






















































































































































1988 1991 1994 1997 2000 2003 2006
year of birth 



























































































































































































































































































































































































































































































































Notes. Means are presented by country over all DHS waves. Means are weighted using sample weights. Observations are the number 






















































































































Mali  0.438  0.407  0.392  0.014  0.987  31273 
 


















































Notes. Means are presented by country over all DHS waves. Means are weighted using sample weights. Observations are the number 
responding to the question of whether a trained professional attended the birth.    Table 4. Children’s immunizations 
  Indicator: Child was not immunized against:   
 
 
Polio at birth  Polio  Measles  BCG  DPT  Observations 
(DPT) 
Burkina Faso  0.497  0.249  0.462  0.252  0.297  20252 
Cameroon  0.408  0.189  0.475  0.220  0.274  11707 
Cote d’Ivoire  0.908  0.278  0.536  0.271  0.363  5392 
Ethiopia  0.876  0.295  0.708  0.517  0.556  18546 
Ghana  0.561  0.162  0.371  0.168  0.180  8753 
Guinea  0.475  0.285  0.512  0.254  0.316  10635 
Kenya  0.397  0.117  0.338  0.098  0.117  14413 
Malawi  0.589  0.116  0.307  0.121  0.115  24536 
Mali  0.550  0.271  0.466  0.295  0.323  26877 
Niger  0.751  0.473  0.664  0.523  0.567  18046 
Senegal  0.543  0.191  0.396  0.163  0.201  15714 
Tanzania  0.548  0.093  0.307  0.085  0.297  13929 
Zambia  0.881  0.118  0.306  0.095  0.132  17568 
Zimbabwe  n.a.  0.242  0.398  0.179  0.250  10480 
Notes. Means are presented by country over all DHS waves, with the exception of the measure of “no polio vaccine at birth.” Because 
only 2 DHS waves conducted earlier than 1992/1993 collected information on this vaccine, means are computed over children born 
from 1993 onward. Means are weighted using sample weights. Observations are the number responding to the question of whether the 







If had antenatal care: 
   











Mean of dependent variable  [0.755]  [0.528]  [0.506]  [0.858]  [0.932] 
 



































































































































Notes: Ordinary Least Squares estimates. The mean of the dependent variable, calculated using sample weights, is in square brackets. 
Standard errors are in parentheses. Mother and child characteristics include the mother’s education in years, the mother’s age in years, 
the child’s age in months, an indicator for the child’s sex, and an indicator of whether the family lived in an urban area. 





Delivered in a 
public or private 
clinic 
 
If delivered in a 
clinic,  
clinic was public 
 
Had a trained 
birth attendant 
 
If delivered in a 
clinic,  
had a trained 
birth attendant 
 























































































































Notes: Ordinary Least Squares estimates. The mean of the dependent variable, calculated using sample weights, is in square brackets. 
Standard errors are in parentheses. Mother and child characteristics include the mother’s education in years, the mother’s age in years, 









































































































































































Notes: Ordinary Least Squares estimates. The mean of the dependent variable, calculated using sample weights, is in square brackets. 
Standard errors are in parentheses. Mother and child characteristics include the mother’s education in years, the mother’s age in 
years, the child’s age in months, an indicator for the child’s sex, and an indicator of whether the family lived in an urban area. 
Table 8. Tests for models with HIV prevalence/birth year interactions dependent variable: 
 
Test: birth year effects 
jointly insignificant  
F (p-value) 
 
Test: birth year/HIV prevalence 
interactions jointly insignificant  
F (p-value) 
Test: birth year/HIV 
interactions follow linear trend 
F (p-value) 
 












12.03 (0.000)  3.43 (0.000) 
 




12.39 (0.000)  3.04 (0.001) 
 




4.45 (0.000)  2.47 (0.008) 
 




10.48 (0.000)  2.65 (0.005) 
 




9.04 (0.000)  3.47 (0.000) 
 




4.57 (0.000)  2.82 (0.000) 
 




18.46 (0.000)  1.39 (0.137) 
If delivered in a clinic: had trained birth attendant  19.90 (0.000)  9.21 (0.000)  7.16 (0.000) 
 
No polio vaccine at birth  143.13 (0.000)  98.50 (0.000)  15.79 (0.000) 
 
No polio vaccine at birth  136.43 (0.000)  92.15 (0.000)  15.30 (0.000) 
 




105.45 (0.000)  27.61 (0.000) 
 




173.20 (0.000)  122.49 (0.000) 
 





77.09 (0.000)  33.26 (0.000) 
 




103.20 (0.000)  41.84 (0.000) 
Note: Each row shows test statistics from a regression of the dependent variable on a set of mother and child controls, regions/country controls, 
birth year indicators, and interactions between the birth year indicators and the HIV prevalence in the country/region from the most recent DHS 
survey (equation 3 in text). The results of these regressions are graphed in Figures 4-8.   Table 9. Problems accessing medical care 
 
 






























A big problem with access to medical care is:  






































































































A big problem with access to medical care is:  




































































Notes. Means are weighted using sample weights. Blank cells indicate the relevant question was not asked in the survey. 